Successful peficitinib addition on anti-MDA5 antibody-positive dermatomyositis refractory to triple therapy and glucocorticoid reduction

Anti-melanoma differentiation–associated gene 5 antibody-positive dermatomyositis is the poorest prognosis of all dermatomyositis due to its associated rapidly progressive interstitial lung disease. Intensive treatment is required from the onset and triple therapy with prednisolone, calcineurin inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oba, Yuki, Yamanouchi, Masayuki, Ikuma, Daisuke, Mizuno, Hiroki, Inoue, Noriko, Sekine, Akinari, Hasegawa, Eiko, Suwabe, Tatsuya, Sawa, Naoki, Ubara, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726841/
https://www.ncbi.nlm.nih.gov/pubmed/36507062
http://dx.doi.org/10.1177/2050313X221141277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726841/
https://www.ncbi.nlm.nih.gov/pubmed/36507062
http://dx.doi.org/10.1177/2050313X221141277

Ejemplares similares